Doctor profile · Federal record
Dr. Mehjabein Khan, MD
Rheumatology Physician (CMS: Rheumatology) · Kenosha, WI
- NPI 1477500312
- Accepts Medicare
- MIPS 79.6 / 100 · 2023
- 36 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
6308 8Th Avenue, Suite 108
Kenosha, WI 53143
(262) 653-5300
fax (262) 653-5412
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- June 13, 2012
- Year of graduation
- 1990 — 36 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Wisconsin #46826
- Medicaid
- WI #34551100
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1477500312. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,339
Distinct HCPCS
10
Medicare allowed
$135,092
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 2,400 | 24 | $22 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 904 | 113 | $1 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 345 | 180 | $85 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 279 | 143 | $120 | |
20610 |
Aspiration and/or injection of fluid from large joint | 132 | 73 | $68 | |
96372 |
Injection of drug or substance under skin or into muscle | 117 | 53 | $13 | |
20550 |
Injection into tendon or ligament | 63 | 41 | $41 | |
J1040 |
Injection, methylprednisolone acetate, 80 mg | 25 | 21 | $11 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 23 | 23 | $105 | |
20600 |
Aspiration and/or injection of fluid from small joint | 22 | 17 | $45 |
In context: peer comparison
Among 2 peers in Kenosha Rheumatology Physician, average services per provider: 778. This provider delivers 5.6× the peer median.Open Payments
Industry payments received
All-time total
$923
Transactions
41
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 9 | $172.51 | |
| Amgen INC. | 7 | $135.72 | |
| AstraZeneca Pharmaceuticals Lp | 4 | $90.94 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 3 | $73.80 | |
| Ani Pharmaceuticals, INC. | 2 | $59.96 | |
| GlaxoSmithKline, LLC. | 3 | $50.45 | |
| Biocon Biologics INC | 2 | $48.28 | |
| Pfizer INC. | 2 | $47.56 | |
| Ucb, INC. | 2 | $32.68 | |
| Lilly USA, LLC | 2 | $31.21 | |
| Genzyme Corporation | 1 | $26.22 | |
| Novartis Pharmaceuticals Corporation | 1 | $23.98 | |
| Alexion Pharmaceuticals, INC. | 1 | $23.43 | |
| Aurinia Pharma U.S., INC. | 1 | $21.68 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $19.24 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,089
Patients
548
Total drug cost
$793,959
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate | Generic | 317 | 83 | $26,112 |
| Methotrexate (Methotrexate Sodium) | Brand | 314 | 68 | $9,861 |
| Prednisone | Generic | 280 | 127 | $2,715 |
| Tizanidine Hcl | Generic | 222 | 57 | $4,006 |
| Baclofen | Generic | 152 | 42 | $2,537 |
| Sulfasalazine | Generic | 134 | 30 | $5,251 |
| Tramadol Hcl | Generic | 102 | 16 | $723 |
| Leflunomide | Generic | 94 | 31 | $5,860 |
| Duloxetine Hcl | Generic | 91 | 25 | $2,253 |
| Humira(Cf) Pen (Adalimumab) | Brand | 81 | 0 | $725,838 |
Hospital affiliations
Frequently asked questions
What is Dr. Mehjabein Khan's medical specialty?
Dr. Mehjabein Khan practices Rheumatology Physician in Kenosha, WI.
Where does Dr. Mehjabein Khan practice?
Dr. Mehjabein Khan practices at 6308 8Th Avenue, Kenosha, WI 53143. Office phone: 2626535300.
What is Dr. Mehjabein Khan's NPI?
Dr. Mehjabein Khan's National Provider Identifier (NPI) is 1477500312, issued by NPPES.
Does Dr. Mehjabein Khan accept Medicare assignment?
Yes. Dr. Mehjabein Khan accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mehjabein Khan commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS J3301); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.